By InvitationPhase 2

Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia

24 participantsStarted 2003-05-06

Plain-language summary

This study evaluates the addition of Acipimox or placebo to exercise on growth hormone release and ghrelin secretion in bulimic patients and in healthy women. Two groups of participants will receive Acipimox together with exercise versus identical placebo with exercise.

Who can participate

Age range18 Years – 30 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with a diagnosis of bulimia nervosa * Body mass index (BMI) between 18 and 23 kg/m2 Exclusion Criteria: * History of heart disease * History of bleeding disorders * Subjects with diabetes type 1 or 2, hypo- or hyperthyroidism * Subjects with hepatogastroenteric disease * Pregnant, trying to become pregnant or breast feeding * Patients with other psychiatric diseases

What they're measuring

Changes in plasma growth hormone levels

Timeframe: baseline and over a total 2 weeks

Trial details

NCT IDNCT03338387

SponsorCharles University, Czech Republic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2007-12-16

View on ClinicalTrials.gov More Eating Disorder trials